Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85
Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916
metoclopramide levodopa

decreases effects

Severe Study
metoclopramide prilocaine

increases risk of methaemoglobinaemia

Severe Theoretical
metoclopramide topicalanaesthetics,local

increases risk of methaemoglobinaemia

Severe Theoretical
mexiletine antiarrhythmics

increases risk of torsadedepointes

Severe Theoretical
mexiletine betablockers,selective

increases risk of cardiovascularadverseeffects

Severe Theoretical
mexiletine tizanidine

increases exposure

Severe Study
mexiletinepotentially coumarins

affects exposure

Severe Theoretical
mexiletinepotentially lithium

affects exposure

Severe Theoretical
mexiletinepotentially warfarin

affects exposure

Severe Theoretical
miconazole antihistamines,non-sedating

increases exposure

Severe Theoretical
miconazole ergometrine

increases exposure

Severe Theoretical
miconazole ergotamine

increases exposure

Severe Theoretical
miconazole mizolastine

increases exposure

Severe Theoretical
miconazole oralbenzodiazepines

increases exposure

Severe Theoretical
mitotane abemaciclib

decreases exposure

Severe Study
mitotane acalabrutinib

decreases exposure

Severe Study
mitotane anti-androgens

decreases exposure

Severe Study
mitotane antiarrhythmics

decreases exposure

Severe Study
mitotane antifungals,azoles

decreases exposure

Severe Study
mitotane antimalarials

decreases exposure

Severe Study
mitotane antimalarials

decreases concentration

Severe Theoretical
mitotane aprepitant

decreases exposure

Severe Study
mitotane artemether

decreases exposure

Severe Study
mitotane artemetherwithlumefantrine

decreases exposure

Severe Study
mitotane bedaquiline

decreases exposure

Severe Study
mitotane bortezomib

decreases exposure

Severe Study
mitotane bosentan

affects exposure

Severe Study
mitotane cabazitaxel

decreases exposure

Severe Study
mitotane crizotinib

decreases exposure

Severe Study
mitotane darolutamide

decreases exposure

Severe Study
mitotane dasatinib

decreases exposure

Severe Study
mitotane delamanid

decreases exposure

Severe Study
mitotane disopyramide

decreases exposure

Severe Study
mitotane dronedarone

decreases exposure

Severe Study
mitotane elvitegravir

decreases concentration

Severe Study
mitotane endothelinreceptorantagonists

affects exposure

Severe Study
mitotane endothelinreceptorantagonists

decreases exposure

Severe Study
mitotane fosaprepitant

decreases exposure

Severe Theoretical
mitotane isavuconazole

decreases exposure

Severe Study
mitotane larotrectinib

decreases exposure

Severe Study
mitotane mineralocorticoidreceptorantagonists

decreases exposure

Severe Theoretical
mitotane mobocertinib

decreases exposure

Severe Study
mitotane naldemedine

decreases exposure

Severe Study
mitotane naloxegol

decreases exposure

Severe Study
mitotane neurokinin-

decreases exposure

Severe Theoretical
mitotane nilotinib

decreases exposure

Severe Study
mitotane nirmatrelvirboostedwithritonavir

decreases exposure

Severe Study
mitotane osimertinib

decreases exposure

Severe Study
mitotane paclitaxel

decreases exposure

Severe Study
mitotane panobinostat

decreases exposure

Severe Theoretical
Prev 1 ... 9 10 11 12 13 ... 126 Next
6278 interactions
Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.